BCL3 anticorps (C-Term)
Aperçu rapide pour BCL3 anticorps (C-Term) (ABIN6260225)
Antigène
Voir toutes BCL3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- BCL-3 Antibody detects endogenous levels of total BCL-3.
-
Homologie
- Horse
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human BCL-3, corresponding to a region within C-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Date de péremption
- 12 months
-
-
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
-
Autre désignation
- BCL3
-
Sujet
-
Description: Contributes to the regulation of transcriptional activation of NF-kappa-B target genes. In the cytoplasm, inhibits the nuclear translocation of the NF-kappa-B p50 subunit. In the nucleus, acts as transcriptional activator that promotes transcription of NF-kappa-B target genes. Contributes to the regulation of cell proliferation (By similarity).
Gene: BCL3
-
Poids moléculaire
- 47584
-
ID gène
- 602
-
UniProt
- P20749
-
Pathways
- Signalisation NF-kappaB, Maintenance of Protein Location, Protein targeting to Nucleus
Antigène
-